These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 23026595

  • 1. Hyperuricemia in adult renal allograft recipients: prevalence and predictors.
    Malheiro J, Almeida M, Fonseca I, Martins LS, Pedroso S, Dias L, Henriques AC, Cabrita A.
    Transplant Proc; 2012 Oct; 44(8):2369-72. PubMed ID: 23026595
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hyperuricemia at 1 year after renal transplantation, its prevalence, associated factors, and graft survival.
    Numakura K, Satoh S, Tsuchiya N, Saito M, Maita S, Obara T, Tsuruta H, Inoue T, Narita S, Horikawa Y, Kagaya H, Miura M, Habuchi T.
    Transplantation; 2012 Jul 27; 94(2):145-51. PubMed ID: 22728291
    [Abstract] [Full Text] [Related]

  • 4. Hyperuricemia in kidney transplant recipients with intact graft function.
    Kim KM, Kim SS, Han DJ, Yang WS, Park JS, Park SK.
    Transplant Proc; 2010 Nov 27; 42(9):3562-7. PubMed ID: 21094816
    [Abstract] [Full Text] [Related]

  • 5. Effect of allopurinol on slowing allograft functional decline in kidney transplant recipients.
    Osadchuk L, Bashir MH, Tangirala B, Marcus RJ, Nashar K, Hussain SM, Sureshkumar KK.
    Exp Clin Transplant; 2014 Jun 27; 12(3):190-4. PubMed ID: 24907717
    [Abstract] [Full Text] [Related]

  • 6. Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy.
    Akalin E, Ganeshan SV, Winston J, Muntner P.
    Transplantation; 2008 Sep 15; 86(5):652-8. PubMed ID: 18791445
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Uric acid contributes to glomerular filtration rate deterioration in renal transplantation.
    Kim KM, Kim SS, Yun S, Lee MS, Han DJ, Yang WS, Park JS, Park SK.
    Nephron Clin Pract; 2011 Sep 15; 118(2):c136-42. PubMed ID: 21150221
    [Abstract] [Full Text] [Related]

  • 9. Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk.
    Bandukwala F, Huang M, Zaltzman JS, Nash MM, Prasad GV.
    Am J Cardiol; 2009 Mar 15; 103(6):867-71. PubMed ID: 19268747
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preservation of renal function during gout treatment with febuxostat: a quantitative study.
    Whelton A, MacDonald PA, Chefo S, Gunawardhana L.
    Postgrad Med; 2013 Jan 15; 125(1):106-14. PubMed ID: 23391676
    [Abstract] [Full Text] [Related]

  • 12. Role of uric acid in post-renal transplantation hypertension.
    Bandukwala F, Huang M, Prasad GV.
    Transplant Proc; 2009 Jun 15; 41(5):1634-6. PubMed ID: 19545696
    [Abstract] [Full Text] [Related]

  • 13. Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
    Chohan S, Becker MA, MacDonald PA, Chefo S, Jackson RL.
    Arthritis Care Res (Hoboken); 2012 Feb 15; 64(2):256-61. PubMed ID: 22052584
    [Abstract] [Full Text] [Related]

  • 14. Effects of hyperuricemia on renal function in pediatric renal transplant recipients.
    Fidan C, Kantar A, Baskın E, Gülleroğlu K, Akdur A, Moray G, Haberal M.
    Exp Clin Transplant; 2015 Apr 15; 13 Suppl 1():247-50. PubMed ID: 25894164
    [Abstract] [Full Text] [Related]

  • 15. Uric acid, allopurinol therapy, and mortality in patients with acute heart failure--results of the Acute HEart FAilure Database registry.
    Málek F, Ošťádal P, Pařenica J, Jarkovský J, Vítovec J, Widimský P, Linhart A, Fedorco M, Coufal Z, Miklík R, Krűger A, Vondraková D, Špinar J.
    J Crit Care; 2012 Dec 15; 27(6):737.e11-24. PubMed ID: 22699032
    [Abstract] [Full Text] [Related]

  • 16. The independent association between serum uric acid and graft outcomes after kidney transplantation.
    Haririan A, Nogueira JM, Zandi-Nejad K, Aiyer R, Hurley H, Cooper M, Klassen DK, Weir MR.
    Transplantation; 2010 Mar 15; 89(5):573-9. PubMed ID: 19997058
    [Abstract] [Full Text] [Related]

  • 17. Is uric acid a predictive factor for graft dysfunction in renal transplant recipients?
    Akgul A, Bilgic A, Ibis A, Ozdemir FN, Arat Z, Haberal M.
    Transplant Proc; 2007 May 15; 39(4):1023-6. PubMed ID: 17524881
    [Abstract] [Full Text] [Related]

  • 18. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR, Becker MA, Wortmann RL, Macdonald PA, Hunt B, Streit J, Lademacher C, Joseph-Ridge N.
    Arthritis Rheum; 2008 Nov 15; 59(11):1540-8. PubMed ID: 18975369
    [Abstract] [Full Text] [Related]

  • 19. Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.
    Neri L, Rocca Rey LA, Lentine KL, Hinyard LJ, Pinsky B, Xiao H, Dukes J, Schnitzler MA.
    Am J Kidney Dis; 2011 Sep 15; 58(3):398-408. PubMed ID: 21783292
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study.
    Zhu X, Chen J, Han F, Cheng M, Xu L, Zhang L, Ding X, Le Y.
    Transplant Proc; 2009 Nov 15; 41(9):3736-42. PubMed ID: 19917377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.